Dextech Medical AB announced earnings results for the fourth quarter ended June 30, 2021. For the fourth quarter, the company announced sales was SEK 164,000 compared to SEK 165,000 a year ago. Operating loss was SEK 1.488 million compared to SEK 1.924 million a year ago. Net loss was SEK 1.488 million compared to SEK 1.924 million a year ago. Basic loss per share from continuing operations was SEK 0.1 compared to SEK 0.13 a year ago. For the full year, sales was SEK 635,000 compared to SEK 596,000 a year ago. Operating loss was SEK 6.075 million compared to SEK 7.714 million a year ago. Net loss was SEK 6.075 million compared to SEK 7.714 million a year ago. Basic loss per share from continuing operations was SEK 0.41 compared to SEK 0.52 a year ago.